[Studies on the systemic effect of extensively applied topical steroids].
D015065:17-Hydroxycorticosteroids / Q000097:blood; D000085:Acetates / Q000627:therapeutic use; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D003276:Contraceptives, Oral / Q000494:pharmacology; D004485:Eczema / Q000188:drug therapy; D005260:Female; D005461:Fluorine / Q000627:therapeutic use; D005470:Fluorometry; D005477:Fluprednisolone / Q000008:administration & dosage; D005938:Glucocorticoids / Q000097:blood*; D006801:Humans; D006889:Hydroxycorticosteroids / Q000097:blood; D008875:Middle Aged; D011239:Prednisolone; D011536:Prurigo / Q000188:drug therapy; D011537:Pruritus / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012869:Skin Absorption; D012871:Skin Diseases / Q000188:drug therapy*; D014581:Urticaria / Q000188:drug therapy; D014631:Valerates
D015065:17-Hydroxycorticosteroids; D000085:Acetates; D000893:Anti-Inflammatory Agents; D003276:Contraceptives, Oral; D005938:Glucocorticoids; D006889:Hydroxycorticosteroids; D014631:Valerates; D005461:Fluorine; D001623:Betamethasone; D005477:Fluprednisolone; D011239:Prednisolone
Untersuchungen zur Frage der systemischen Wirkung grossflächig applizierter Stereoidexterna.